Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs Medical Center

Laryngoscope

Volumn 123, Issue 9, 2013, Pages 2170-2175

  Sandulache, Vlad C ^a   Kubik, Mark W ^a   Skinner, Heath D ^b   Malsky, Joseph A ^a   Gelbard, Alexander H ^a   Zevallos, Jose P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

larynx; outcomes; Race; survival; veteran

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; COMORBIDITY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ETHNICITY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INDUCTION CHEMOTHERAPY; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEGRO; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RACE; RADIATION DOSE; RECURRENCE RISK; RETROSPECTIVE STUDY; SMOKING; TERTIARY HEALTH CARE; TIME TO TREATMENT; TREATMENT DURATION; VETERANS HEALTH;

LARYNX; OUTCOMES; RACE; SURVIVAL; VETERAN;

AFRICAN AMERICANS; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HOSPITALS, VETERANS; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883141618     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24058     Document Type: Article

References (14)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
3. Chen AY, Schrag NM, Halpern M, Stewart A, Ward EM,. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg 2007; 133: 784-790.
4. Chen AY, Halpern M,. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1270-1276.
5. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, Symons MJ,. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 1999; 10: 513-523.
6. Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR,. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck 1999; 21: 297-309.
7. Murdock JM, Gluckman JL,. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate? Cancer 2001; 91: 279-283.
8. Gourin CG, Podolsky RH,. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006; 116: 1093-1106.
9. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 1993; 85: 465-473.
10. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) 2009; 2: 776-781.
11. Naff JL, Cote ML, Wenzlaff AS, Schwartz AG,. Racial differences in cancer risk among relatives of patients with early onset lung cancer. Chest 2007; 131: 1289-1294.
12. Robinson CN, Balentine CJ, Marshall CL, et al. Ethnic disparities are reduced in VA colon cancer patients. Am J Surg 2010; 200: 636-639.
13. Al-Othman MO, Morris CG, Logan HL, Hinerman RW, Amdur RJ, Mendenhall WM,. Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck. Cancer 2003; 98: 2467-2472.
14. Chen LM, Li G, Reitzel LR, et al. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila) 2009; 2: 782-791.